Response to a Water Bolus in Long Term Oral Contraceptive Users. 2022

Whitley C Atkins, and Brendon P McDermott, and Abigail T Colburn, and Stavros A Kavouras
Exercise Science Research Center, Department of Health and Human Performance, Fayetteville, AR, United States.

The purpose of our study was to determine the responses to an acute water bolus in long-term oral contraception (OCP) users. Seventeen female volunteers (27 ± 5 y, 64.1 ± 13.7 kg, 39.6 ± 5.9 kg/LBM) provided consent and enrolled in our study. All were long-term OCP users and participated in two trials, one during the active pill (High Hormone, HH) dose of their prescribed OCP and one during the sham pill (Low Hormone, LH) dose. Participants reported to the laboratory euhydrated, were fed breakfast, remained seated for 60 min and were provided a bolus of room temperature water in the amount of 12 mL/kg/LBM. Urine output over 180 min was measured. Nude body mass was measured pre- and post-trial. Urine specific gravity (USG) and urine osmolality were analyzed. Between trials, there were no differences in 3-h total urine volume (P = 0.296), 3-h USG (P = 0.225), 3-h urine osmolality (P = 0.088), or 3-h urine frequency (P = 0.367). Heart rate was not different between trials (P = 0.792) nor over time (P = 0.731). Mean arterial pressure was not different between trials (P = 0.099) nor over time (P = 0.262). Perceived thirst demonstrated a significant main effect for increasing over time regardless of trial (P < 0.001) but there was no difference between trials (P = 0.731). The urgency to void was not different between trials (P = 0.149) nor over time (P = 0.615). Plasma volume change was not different between trials (P = 0.847) (HH: -3.4 ± 5.0, LH post: -3.8 ± 4.5%) and plasma osmolality did not differ between trials (P = 0.290) nor over time (P = 0.967) (HH pre: 290 ± 4, HH post: 289 ± 4, LH pre: 291 ± 4, LH post: 291 ± 4 mosm/L). Blood glucose significantly decreased over time (P < 0.001) but there was no difference between trials (P = 0.780) (HH pre: 95.9 ± 113.9, HH post: 86.8 ± 6.5, LH pre: 95.9 ± 13.5, LH post: 84.6 ± 9.4 mmol/L). Copeptin concentration did not differ between phases of OCP use (P = 0.645) nor from pre- to post-trial (P = 0.787) Despite fluctuations in hormone concentrations, responses to a water bolus seem to be unaffected in OCP users in euhydrated, resting conditions.

UI MeSH Term Description Entries

Related Publications

Whitley C Atkins, and Brendon P McDermott, and Abigail T Colburn, and Stavros A Kavouras
February 1971, Obstetrics and gynecology,
Whitley C Atkins, and Brendon P McDermott, and Abigail T Colburn, and Stavros A Kavouras
August 1993, The Journal of clinical endocrinology and metabolism,
Whitley C Atkins, and Brendon P McDermott, and Abigail T Colburn, and Stavros A Kavouras
May 1972, Obstetrics and gynecology,
Whitley C Atkins, and Brendon P McDermott, and Abigail T Colburn, and Stavros A Kavouras
May 1965, British medical journal,
Whitley C Atkins, and Brendon P McDermott, and Abigail T Colburn, and Stavros A Kavouras
February 1994, American journal of obstetrics and gynecology,
Whitley C Atkins, and Brendon P McDermott, and Abigail T Colburn, and Stavros A Kavouras
March 1973, Lancet (London, England),
Whitley C Atkins, and Brendon P McDermott, and Abigail T Colburn, and Stavros A Kavouras
June 1980, Bulletin. Kulliyat Tibb al-Iskandariyah,
Whitley C Atkins, and Brendon P McDermott, and Abigail T Colburn, and Stavros A Kavouras
April 1982, The Journal of reproductive medicine,
Whitley C Atkins, and Brendon P McDermott, and Abigail T Colburn, and Stavros A Kavouras
March 1981, Lancet (London, England),
Whitley C Atkins, and Brendon P McDermott, and Abigail T Colburn, and Stavros A Kavouras
December 1996, Liver,
Copied contents to your clipboard!